1 min read
Add as a preferred source on GooglePAVmed Expects $1.2 Million Adjusted Loss in Third Quarter
The company also expects a loss of $0.19 per common share. Operating expenses were roughly $6.8 million, including $1 million in stock-based compensation.
PAVmed Inc. expects a non-GAAP adjusted net loss of about $1.2 million for the third quarter, or a loss of $0.19 per common share.
Operating expenses were roughly $6.8 million for the quarter. Stock-based compensation accounted for $1 million of that total.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.